Lung cancer

Cancer research

New Research from Memorial Sloan Kettering Cancer Center Investigates Immunotherapy, Surgery Outcomes in Older Patients, AI in Oncology, and Cancer Trained Large Language Models

New research from Memorial Sloan Kettering Cancer Center (MSK) is investigating whether introducing new mutations could make immunotherapy more effective against some cancers, showing that people in their 90s who underwent lung cancer surgery had positive outcomes, and sharing lessons on the responsible governance of artificial intelligence in oncology. Previous

Cancer research

New Insights into Lung Cancer: FAT1 Mutation-Related Risk Signature Predicts Survival Risk and Tumor Immunogenicity

Researchers from Shandong, People's Republic of China, have made significant breakthroughs in understanding the relationship between FAT1 mutations and lung adenocarcinoma (LUAD). The study aimed to identify a FAT1 mutation-related transcriptomic risk signature to assess the survival risks and immune status of LUAD patients. The researchers collected a